AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among nursing home residents e ...

(“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Scripps Research scientists engineered stable RSV and hMPV F proteins, overcoming instability challenges to design effective ...

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, ...

New COVID-19 research uncovers viral behavior insights, driving innovative treatments with Northwestern Medicine's support.

Vaccination rates for Covid and the flu are low for adults in the U.S. so far this season, according to a new CDC report.

By Kristen Hwang, Calmatters An Alameda County child with mild upper respiratory symptoms tested positive for bird flu, state ...

Knoxville, filed a bill Monday that would require Arkansas' Medicaid program to provide blood pressure monitors to pregnant ...

Respiratory virus activity remained low in the United States last week, with COVID levels continuing to decline, but ...